A Southern California firm is recalling an herbal female sexual enhancement supplement because it contains a drug not listed on the label.
Irvine-based Regeneca said Saturday it will voluntarily pull RegenArouse after a Food and Drug Administration analysis confirmed the presence of Tadafil.
Tadalafil is an FDA-approved drug used as treatment for male erectile dysfunction. It is not listed among RegenArouse’s ingredients.
For some users, Tadafil could interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
On its web site, RegenArouse is billed as an all-natural, drug-free intimacy enhancer for women.
Regeneca has distributed the supplement in the U.S. and Puerto Rico via the internet since November 2011.
Consumers can return any unused product for an exchange or a full refund.
Was this article valuable?
Here are more articles you may enjoy.
Catastrophe Bonds’ Huge Market Gains Put Reinsurers on Backfoot 
GEICO Sues Medical Firms in Florida, NY Over Alleged No-Fault Auto Fraud 
Rotting Apple: Berkley Explains Property Market, Company Appetite 
Rivian Agrees to Pay $250 Million to Settle IPO Fraud Lawsuit 
